NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, today finalized an agreement with River’s Edge Pharmaceuticals that significantly expands the Company’s product portfolio with an exclusive license to five new prescription dermatological product formulations.
